Thermo Fisher Scientific has agreed to acquire Sanofi's sterilized fill-finish and packaging facility in Ridgefield, New Jersey, employing over 200 staff who will join Thermo Fisher post-closing expected in the second half of 2025. The acquisition will expand Thermo Fisher's U.S. manufacturing capacity to support pharma and biotech customers for essential medicines. The facility will integrate into Thermo Fisher’s Laboratory Products and Biopharma Services segment, complementing its existing sterile manufacturing network and enhancing the company’s service offerings and capabilities.